Legal Opinion
Amgen Inc. v. Sandoz Inc.
Court of Appeals for the Federal Circuit
Decided July 21, 2015No. 2015-1499PublishedCited by 9 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge LOURIE.
Opinion concurring in part, dissenting in part filed by Circuit Judge NEWMAN.
Opinion dissenting in part filed by Circuit Judge CHEN.
LOURIE, Circuit Judge.
This appeal presents issues of first impression relating to the Biologies Price Competition and Innovation Act of 2009 (“BPCIA”), Pub.L. No. 111-148, §§ 7001-7003, 124 Stat. 119, 804-21 (2010). Amgen Inc. and Amgen Manufacturing Ltd. (collectively, “Amgen”) appeal from the decision of the United States District Court for the Northern District of California (1) dismissing Amgen’s state law…
2Cases cited15 opinions
- Russello v. United StatesSupreme Court of the United States · 1983
- TRW Inc. v. AndrewsSupreme Court of the United States · 2001
- Ruckelshaus v. Monsanto Co.Supreme Court of the United States · 1984
- National Ass'n of Home Builders v. Defenders of WildlifeSupreme Court of the United States · 2007
- Marx v. General Revenue Corp.Supreme Court of the United States · 2013
10 more not listed; retrieve them via the Exa API.
3Cited by9 opinions
- Sandoz Inc. v. Amgen Inc.Supreme Court of the United States · 2017
- Amgen Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2019
- Amgen Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2017
- Amgen Inc. v. Hospira, Inc.Court of Appeals for the Federal Circuit · 2017
- Amgen Inc. v. Apotex Inc.Court of Appeals for the Federal Circuit · 2016
4 more not listed; retrieve them via the Exa API.